🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-07
Trial ID
NCT00146562
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
The purpose of this trial is to compare the 3-year disease-free survival of...
Status
Unknown
Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-02-22
Trial ID
NCT03876886
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness and tolerability...
Status
Completed
Location
Advanced Medical Specialties
Start Date
2005-11
Trial ID
NCT00270894
Treatments Being Tested
The purpose of this study is to assess the feasibility of dose-dense doxoru...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center ,Norris Cotton Cancer Center
Start Date
2011-03-03
Trial ID
NCT01328249
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin , cyc...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2004-10
Trial ID
NCT00093795
Treatments Being Tested
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
University Hospital Brno
Start Date
2004-02
Trial ID
NCT00290667
In this trial investigators propose to assess the dose dense, G-CSF support...
Status
Completed
Location
University Hospital of Crete
Start Date
2007-10
Trial ID
NCT01985724
Treatments Being Tested